Immunogenic cell death and tertiary lymphoid structures jointly define dysregulated antitumor immune states and therapeutic vulnerability in lung adenocarcinoma.
- DOI
- 10.3389/fimmu.2026.1917959
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1917959,
title = {Immunogenic cell death and tertiary lymphoid structures jointly define dysregulated antitumor immune states and therapeutic vulnerability in lung adenocarcinoma.},
author = {Lu Y and Sun Y and Meng Y and Huang Q and Zhang Y and Zhou X and Liu J and Sang M},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1917959},
url = {https://doi.org/10.3389/fimmu.2026.1917959}
}RIS
TY - JOUR TI - Immunogenic cell death and tertiary lymphoid structures jointly define dysregulated antitumor immune states and therapeutic vulnerability in lung adenocarcinoma. AU - Lu Y AU - Sun Y AU - Meng Y AU - Huang Q AU - Zhang Y AU - Zhou X AU - Liu J AU - Sang M PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1917959 UR - https://doi.org/10.3389/fimmu.2026.1917959 ER -
APA
Y, L., Y, S., Y, M., Q, H., Y, Z., X, Z., J, L., & M, S. (2026). Immunogenic cell death and tertiary lymphoid structures jointly define dysregulated antitumor immune states and therapeutic vulnerability in lung adenocarcinoma.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1917959
Source records
- pubmed · retrieved 2026-11-10T18:05:08.468Z